HuGE Literature Finder
Records
1
-
1
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. Oncotarget 2018 Jan 9 (8): 7859-7866. Cremolini Chiara, Del Re Marzia, Antoniotti Carlotta, Lonardi Sara, Bergamo Francesca, Loupakis Fotios, Borelli Beatrice, Marmorino Federica, Citi Valentina, Cortesi Enrico, Moretto Roberto, Ronzoni Monica, Tomasello Gianluca, Zaniboni Alberto, Racca Patrizia, Buonadonna Angela, Allegrini Giacomo, Ricci Vincenzo, Di Donato Samantha, Zagonel Vittorina, Boni Luca, Falcone Alfredo, Danesi Roma |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: